To conclude, we can reasonably anticipate: (1) The use of next-generation sequencing technologies, such as RNA sequencing, and other omics techniques to further evaluate the molecular basis of PPARγ regulation of EC dysfunction in the context of atherosclerosis. The gene discussed is PPARG; the disease is atherosclerosis.